Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
about
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionAlternate Ways to Quantify Antibodies.The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes.ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.Higher Sensitivity and Earlier Identification of Celiac Disease Autoimmunity by a Nonradioactive Assay for Transglutaminase Autoantibodies.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Staging the progression to type 1 diabetes with prediagnostic markersA novel LIPS assay for insulin autoantibodies.Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.Understanding Pre-Type 1 Diabetes: The Key to Prevention.
P2860
Q30732418-832DFE95-6C72-4071-A405-60AE3DD47D64Q36366700-EEEB78AE-BC54-433E-AE6D-6869F3F2041FQ36547636-B3F8B8F8-C67F-4101-960D-D43F4F4EFB97Q36820754-D2053B57-1C7C-45AE-AEB5-894EF2132A82Q37062268-0D6C5677-0862-4AAF-BAB6-0F5B41497F9DQ37588731-7E79188C-F4B9-421C-A5E1-ABCFFEF40823Q37659402-022E10AB-2B1C-48E6-8C59-3A7928F1F0A3Q38837965-BD6E5819-4707-454C-A173-718A3DC07118Q38846782-38E7DA3F-D424-480F-B645-FA4DC7E7C8ACQ48300084-B945FFBD-B44C-4C28-BB4D-CF2FDCCB157DQ49325874-BB59D3EA-4388-4FEE-9D4D-0BCF69B9BEFFQ51146610-C95CC69D-273F-4637-9F3A-65286D3444AEQ53199203-F7D12830-9633-4094-8881-E6EE9525CA57Q55016896-C637BDF2-FA6F-4D44-86B9-C3AFCA3338D8
P2860
Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@ast
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@en
type
label
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@ast
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@en
prefLabel
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@ast
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@en
P2093
P2860
P356
P1476
Electrochemiluminescence assay ...... ction of type 1 diabetes risk.
@en
P2093
Andrea K Steck
Dongmei Miao
Jeffrey Krischer
K Michelle Guyer
Ling Jiang
Sarah M Muller
Taylor Armstrong
Type 1 Diabetes TrialNet Study Group
P2860
P304
P356
10.1089/DIA.2014.0186
P577
2015-01-06T00:00:00Z